| N | 6256 | | 13,241 | |
| Women, % | 61.6 | | 60.5 | |
| Age mean (SD) | 52.0 | (14.5) | 56.1 | (16.3) |
| Women | 53.1 | (14.5) | 56.0 | (16.6) |
| Men | 50.3 | (14.3) | 56.3 | (15.8) |
| Antidepressants |
| Baseline rate, % | 11.8 | | 10.9 | |
| Controls, % | 6.6 | | 7.6 | |
| Difference (95% c.i.) | 5.2 | (4.35–5.99) | 3.3 | (2.77–3.87) |
| Benzodiazepine-related hypnotics |
| Baseline rate, % | 10.7 | | 10.4 | |
| Controls, % | 6.6 | | 7.6 | |
| Difference (95% c.i.) | 4.1 | 3.34–4.92 | 2.8 | 2.25–3.33 |
| Number of drugs (substances, 3 months before index) |
| Patients |
| mean (SD) | 6.9 | (4.2) | 6.5 | (3.8) |
| Controls |
| mean (SD) | 2.0 | (3.0) | 2.3 | (3.1) |
| Number of outpatient visits (past 12 months) |
| Patients |
| mean (SD) | 5.6 | (4.1) | 3.0 | (3.7) |
| Controls |
| mean (SD) | 0.8 | (2.3) | 0.8 | (2.4) |
| Proportion, at least one hospitalization (past 12 months) |
| Patients, % | 20 | | 21 | |
| Controls, % | 9 | | 10 | |
